Reservoir divers: Select antiviral cells can access HIV's hideouts

January 31, 2017
The green areas are B cell follicles within germinal centers, specialized areas of lymph nodes where HIV-infected cells hide out. Red spots indicate antiviral T cells. Credit: Rama Rao Amara, Emory Vaccine Center

When someone is HIV-positive and takes antiretroviral drugs, the virus persists in a reservoir of infected cells. Those cells hide out in germinal centers, specialized areas of lymph nodes, which most "killer" antiviral T cells don't have access to.

Scientists at Yerkes National Primate Research Center, Emory University, have identified a group of antiviral T that do have the entry code into , a molecule called CXCR5.

Knowing how to induce antiviral T cells displaying CXCR5 will be important for designing better therapeutic vaccines, as well as efforts to suppress HIV long-term, says Rama Rao Amara, PhD, professor of microbiology and immunology at Yerkes National Primate Research Center and Emory Vaccine Center.

The findings are scheduled for publication in PNAS the week of Jan. 30, 2017.

"We think these cells are good at putting pressure on the virus," Amara says. "They have access to the right locations - germinal centers - and they're functionally superior."

Amara and his colleagues looked for these antiviral cells in experiments with rhesus macaques, which were vaccinated against HIV's relative SIV and then repeatedly exposed to SIV. The vaccine regimens were described in a previous publication.

The vaccines provided good but imperfect protection against pathogenic SIV, which means that a group of 20 animals ended up infected, with a range of viral levels. In some animals, a large fraction (up to 40 percent) of anti-viral CD8 T cells in lymph nodes displayed CXCR5. Having more CXCR5-positive antiviral T cells was strongly associated with better viral control, the researchers found.

T cells can be divided into "helper" cells and "killer" cells, based on their function and the molecules they have on their surfaces. A group of T cells called follicular helper T cells or Tfh cells were already known to be in germinal centers and to display CXCR5. Tfh cells are also considered a major reservoir for HIV and SIV.

When stimulated outside the body, the CXCR5-positive cells can attack and kill virus-infected Tfh cells. Some of the lose CXCR5 upon stimulation, but adding an immune regulatory molecule called TGF-beta can boost the CXCR5 levels.

Co-corresponding author Vijayakumar Velu, PhD, assistant professor at Yerkes, says the CXCR5+ killer cells the team has identified have stem cell-like properties, because they have the capacity to differentiate into both CXCR5+ and CXCR5- cells. The lab of co-author Rafi Ahmed, director of Emory Vaccine Center, has reported analogous cells in mice with chronic viral infections. In addition, a recent Science Translational Medicine paper found similar cells in HIV-infected humans, calling them "follicular CD8 T cells."

"These cells have the potential to infiltrate sites of ongoing viral replication and persistence," Amara says. "Their properties and the ability to induce these cells by vaccination provide a tremendous opportunity to target and reduce the viral reservoir in lymphoid tissues."

Explore further: Specialized regulatory T cell stifles antibody production centers

More information: Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection, PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1621418114

Related Stories

Specialized regulatory T cell stifles antibody production centers

July 25, 2011
A regulatory T cell that expresses three specific genes shuts down the mass production of antibodies launched by the immune system to attack invaders, a team led by scientists at The University of Texas MD Anderson Cancer ...

Immunotherapy agent can disrupt viral reservoir in SIV-infected monkeys

February 25, 2016
An immune-enhancing treatment can push SIV (simian immunodeficiency virus) out of its hideouts in infected monkeys that have the virus controlled with drugs, scientists at Yerkes National Primate Research Center, Emory University ...

Immune cells proposed as HIV hideout don't last in primate model

October 31, 2014
Where does HIV hide? Antiretroviral drugs can usually control the virus, but can't completely eliminate it. So any strategy to eradicate HIV from the body has to take into account not only the main group of immune cells the ...

Team finds molecule that polices TB lung infection, could lead to vaccine

January 2, 2013
The presence of a certain molecule allows the immune system to effectively police tuberculosis (TB) of the lungs and prevent it from turning into an active and deadly infection, according to a new study led by researchers ...

T cell revival through PD-1: Clues for cancer immunotherapy

August 2, 2016
Cancer immunotherapy drugs that block the inhibitory PD-1 pathway have shown success in clinical trials and are now FDA-approved for melanoma, lung cancer and bladder cancer. Yet many patients' tumors do not respond to these ...

HIV vaccines should avoid viral target cells, primate model study suggests

January 2, 2015
Vaccines designed to protect against HIV can backfire and lead to increased rates of infection. This unfortunate effect has been seen in more than one vaccine clinical trial.

Recommended for you

New injectable antiretroviral treatment proved to be as effective as standard oral therapy

August 3, 2017
Intramuscularly administered antiretroviral therapy (ART) may be as effective for HIV treatment as current oral therapies. This is the main conclusion of a Phase II clinical trial carried out by 50 research centers around ...

Research finds home-based kit would increase HIV testing

July 31, 2017
Research led by William Robinson, PhD, Associate Research Professor of Behavioral & Community Health Sciences at LSU Health New Orleans School of Public Health, has found that 86% of heterosexuals who are at high risk for ...

Scientists divulge latest in HIV prevention

July 25, 2017
A far cry from the 1990s "ABC" campaign promoting abstinence and monogamy as HIV protection, scientists reported on new approaches Tuesday allowing people to have all the safe sex they want.

Girl's HIV infection seems under control without AIDS drugs

July 24, 2017
A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines—more evidence that early treatment can occasionally cause a long remission that, ...

Meds by monthly injection might revolutionize HIV care (Update)

July 24, 2017
Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay.

Candidate AIDS vaccine passes early test

July 24, 2017
The three-decade-old quest for an AIDS vaccine received a shot of hope Monday when developers announced that a prototype triggered the immune system in an early phase of human trials.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.